T cell and NK cell lymphoproliferative disorders

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Peripheral T-cell lymphomas (PTCL) and natural killer (NK) cell neoplasms are rare, heterogeneous hematologic malignancies.
• Diagnostic challenges include rarity, morphologic variability, and lack of definitive immunophenotypic markers.
• Clinical behavior often does not correlate with morphology, complicating prognosis and treatment.

Purpose of the Study:

• To provide a comprehensive overview of the diagnosis and management of PTCL and NK cell neoplasms.
• To discuss the pathogenesis of large granular lymphocyte (LGL) leukemia as a model for apoptosis dysregulation.
• To compare treatment strategies for PTCL with diffuse large B-cell lymphomas and review options for specific subtypes.

Main Methods:

• Review of current literature on PTCL and NK cell lymphoma diagnosis and management.
• Discussion of pathogenesis, focusing on large granular lymphocyte (LGL) leukemia.
• Analysis of therapeutic options for anaplastic large cell lymphoma (ALCL) and extranodal PTCL subtypes.

Main Results:

• PTCL and NK cell lymphomas present diagnostic and clinical challenges due to rarity and heterogeneity.
• Large granular lymphocyte (LGL) leukemia serves as a model for understanding dysregulated apoptosis in malignancy and autoimmunity.
• Treatment approaches vary based on PTCL subtype, with ALK-positive ALCL being highly chemosensitive.

Conclusions:

• Accurate diagnosis and tailored management are crucial for PTCL and NK cell neoplasms.
• Understanding pathogenesis, including apoptosis dysregulation, informs therapeutic strategies.
• Further research is needed to optimize treatment for these rare lymphomas, considering differences from B-cell lymphomas.